List of works - Maki Tanioka

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.

scientific article published on 18 July 2014

A Microarray-Based Gene Expression Analysis to Identify Diagnostic Biomarkers for Unknown Primary Cancer ⬇️

scientific article published on May 9, 2013

A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors

scientific article published on 30 January 2012

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy ⬇️

scientific article published on July 16, 2013

An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.

scientific article

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

scientific article published on 25 September 2013

Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study.

scientific article

Clinical characteristics and outcomes of women with stage IV endometrial cancer.

scientific article

Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.

scientific article published on February 2003

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

scientific article

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

scientific article published on 23 July 2018

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

scientific article published on 16 April 2014

Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors ⬇️

scientific article published on December 6, 2011

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

scientific article

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.

scientific article

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

scientific article published on 28 March 2017

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

scientific article published on 26 October 2010

Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.

scientific article published on 9 September 2014

List of works by Maki Tanioka

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.

A Microarray-Based Gene Expression Analysis to Identify Diagnostic Biomarkers for Unknown Primary Cancer ⬇️

A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy ⬇️

An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study.

Clinical characteristics and outcomes of women with stage IV endometrial cancer.

Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors ⬇️

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.